Existing studies have reported that in gallbladder cancer tissues and cells, upstream or downstream molecules of PI3K/AKT signaling pathway, such as EGFR, HER2, and PTEN, etc. [42,43,44], experience gene mutations, amplifications or expression dysregulation. This evidence concerns the gene EGFR and gallbladder cancer.